At Labcyte, our innovations have enabled our customers to enhance personalized medicine programs, streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines and accelerate life science research.
Location: United States, California, San Jose
Employees: 201-500
Phone: +1 408-747-2000
Total raised: $22.5M
Founded date: 2003
Investors 8
Funding Rounds 3
| Date | Series | Amount | Investors |
| 13.05.2015 | - | $17M | - |
| 08.01.2013 | Series D | $5.3M | - |
| 08.11.2011 | Grant | $196K | - |
Mentions in press and media 9
| Date | Title | Description |
| 09.10.2018 | Drug sensitivity and resistance testing could make ‘right to try’ a real thing | The contentious “right to try” bill that President Trump signed into law to help terminally ill patients get access to treatments that might — I emphasize the “might” — cure them or prolong their lives is more wishful thinking than it is re... |
| 20.11.2015 | AstraZeneca expands technological investment in new Cambridge lead discovery centre | AstraZeneca expands technological investment in new Cambridge lead discovery centre 20-11-2015 AstraZeneca today announced three new partnerships that will deliver industry-leading technologies to drive the AstraZeneca MRC UK Centre for Lea... |
| 20.11.2015 | AstraZeneca expands technological investment in new Cambridge lead discovery centre | AstraZeneca today announced three new partnerships that will deliver industry-leading technologies to drive the AstraZeneca MRC UK Centre for Lead Discovery in the search for novel small molecule medicines. The partnerships will ensure stat... |
| 13.05.2015 | Labcyte Receives $17M Credit Facility | Labcyte Inc., a Sunnyvale, California-based global biotechnology tools company, received a $17m credit facility. Oxford Finance and Silicon Valley Bank provided the respurces that include a $10 million senior secured term loan and a $7 mill... |
| 09.01.2013 | Labcyte Closes $5.3M Series D | SUNNYVALE, CA, Privately-held company advancing acoustic liquid handling, today announced it has closed a Series D financing led by the healthymagination fund. >> Click here for more funding data on Labcyte >> To export Labc... |
| 08.01.2013 | Labcyte Closes $5.3M Series D Financing | Labcyte, Inc., a Sunnyvale, California-based global biotechnology tools company, closed a $5.3m Series D financing. The round was led by the healthymagination fund, a part of GE Ventures, and also included current investors Abingworth, Allo... |
| 08.11.2011 | Labcyte Receives $196K Grant from the National Cancer Institute | Labcyte Inc., a Sunnyvale, CA-based global life science instrumentation company, has received a $196K grant from the National Cancer Institute. The award will be used to fund a collaborative cancer biomarker validation program with the Cana... |
| - | Labcyte Partners with GP-write in Large-Scale Genomic Testing. | California, USA. 17 July, 2018. Labcyte Inc., today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts for the Genome P... |
| - | Labcyte Sold to Beckman Coulter. | Dublin, Ireland. 30 January 2019. Seroba portfolio company, Labcyte, has been acquired by Beckman Coulter Life Sciences, part of the larger Danaher Corporation which generates approximately $6.5 billion in annual revenue. Labcyte is best k... |